New technology serves as reminder for the appropriate uses of CRISPR.
Anne Elise Herold Li
Advertisement
Partner in Crowell & Moring's Life Sciences Litigation, Intellectual Property, and Trade Secrets groups in New York
Articles by Anne Elise Herold Li
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Antagonist for Menopausal Hot Flashes
3
FDA Approves Blenrep for Treatment of Replapsed/Refractory Multiple Myeloma
4
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
5
